Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Modeling Acquired Resistance to the Second-Generation Androgen Receptor Antagonist Enzalutamide in the TRAMP Model of Prostate Cancer.

  • Authors : Cerasuolo M; School of Mathematics and Physics, University of Portsmouth, Hampshire, United Kingdom.; Maccarinelli F

Subjects: Androgen Receptor Antagonists/Androgen Receptor Antagonists/Androgen Receptor Antagonists/*pharmacology ; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*pharmacology ; Drug Resistance, Neoplasm/Drug Resistance, Neoplasm/Drug Resistance, Neoplasm/*drug effects

  • Source: Cancer research [Cancer Res] 2020 Apr 01; Vol. 80 (7), pp. 1564-1577. Date of Electronic Publication: 2020 Feb 06.Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model:

تفاصيل العنوان

×
Academic Journal

Novel Selective Agents for the Degradation of Androgen Receptor Variants to Treat Castration-Resistant Prostate Cancer.

  • Authors : Ponnusamy S; Department of Medicine, The University of Tennessee Health Science Center, Memphis, Tennessee.; Coss CC

Subjects: Androgen Receptor Antagonists/Androgen Receptor Antagonists/Androgen Receptor Antagonists/*pharmacology ; Gene Expression Regulation, Neoplastic/Gene Expression Regulation, Neoplastic/Gene Expression Regulation, Neoplastic/*drug effects ; Prostatic Neoplasms, Castration-Resistant/Prostatic Neoplasms, Castration-Resistant/Prostatic Neoplasms, Castration-Resistant/*drug therapy

  • Source: Cancer research [Cancer Res] 2017 Nov 15; Vol. 77 (22), pp. 6282-6298. Date of Electronic Publication: 2017 Oct 04.Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model:

تفاصيل العنوان

×
Academic Journal

BRD9 Is a Critical Regulator of Androgen Receptor Signaling and Prostate Cancer Progression.

  • Authors : Alpsoy A; Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, Indiana.; Utturkar SM

Subjects: Prostatic Neoplasms/Prostatic Neoplasms/Prostatic Neoplasms/*pathology ; Receptors, Androgen/Receptors, Androgen/Receptors, Androgen/*metabolism ; Transcription Factors/Transcription Factors/Transcription Factors/*physiology

  • Source: Cancer research [Cancer Res] 2021 Feb 15; Vol. 81 (4), pp. 820-833. Date of Electronic Publication: 2020 Dec 21.Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model:

تفاصيل العنوان

×
  • 1-10 of  2,786 نتائج ل ""Androgen receptor""